Hims & Hers Acquires MedisourceRx from Nivagen Pharmaceuticals

Hims & Hers Acquires US-based Peptide Facility in California

February 21, 2025

Pharmaceuticals

Hims & Hers Health, Inc. has acquired a US-based peptide manufacturing facility in California to further verticalize its supply chain and expand domestic capabilities for personalized medications. The acquisition, which closed in early February, strengthens Hims & Hers’ ability to meet growing consumer demand for personalized healthcare and peptide-based treatments.

Hims & Hers Acquires Honest Health to Expand UK Footprint

June 14, 2021

Healthcare Services

Hims & Hers Health, Inc. agreed to acquire London-based vertical health platform Honest Health to accelerate the company's expansion into the United Kingdom and Western Europe. The acquisition adds Honest Health’s hair-loss telehealth clinic and compounding pharmacy/fulfillment capabilities to Hims & Hers’ multi-specialty telehealth platform; financial terms were not disclosed.

PAI Pharma Acquires Nivagen Pharmaceuticals

January 8, 2026

Pharmaceuticals

PAI Pharma, an Olympus Partners portfolio company, has acquired Nivagen Pharmaceuticals to add a newly built aseptic sterile-injectable manufacturing facility in Sacramento, California and a pipeline of more than 20 ready-to-use (RTU) injectable products. The add-on expands PAI's sterile injectable capabilities alongside its oral liquid franchise to better serve hospitals and health systems and strengthen U.S. pharmaceutical supply-chain resilience; financial terms were not disclosed.

Hims & Hers Acquires Apostrophe

June 24, 2021

Healthcare Services

Hims & Hers Health, Inc. completed the acquisition of teledermatology specialist Apostrophe to deepen its personalized dermatology offering and integrate Apostrophe's clinical team and compounding pharmacy capabilities. The entire Apostrophe team will join Hims & Hers, with Apostrophe CEO Ben Holber becoming head of Hims & Hers' dermatology business line.

Hims & Hers to Go Public via Merger with Oaktree Acquisition Corp.

October 1, 2020

Healthcare Services

Hims & Hers (Hims, Inc.), a multi-specialty telehealth and consumer health platform, entered a definitive merger agreement with SPAC Oaktree Acquisition Corp. The business combination values the combined company at an approximate $1.6 billion enterprise value and provides up to $280 million of cash (including a $75 million PIPE led by Franklin Templeton and certain Oaktree clients) to accelerate Hims & Hers' growth and expansion into new care categories.

Integrity Marketing Group Acquires MediSource

April 11, 2023

Insurance

Integrity Marketing Group has acquired MediSource, an independent marketing organization (IMO) based in Little Rock, Arkansas. MediSource's leadership, including President RD Roulston, will join Integrity as part of the partnership to expand Integrity's Medicare distribution capabilities and provide MediSource access to Integrity's technology and shared services.